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Introduction: Despite tremor, bradykinesia, and rigidity are the classic motor symptoms of Parkinson’s di-
sease (PD), muscle weakness has also been pointed out as an important motor symptom associated to this 
disease, however, this condition is still poorly studied and the results are inconsistent. Objectives: This study 
aimed to compare the quadriceps muscle strength between individuals with PD and neurologically healthy in-
dividuals matched for age and gender. We also compared muscle strength in the limb more and less affected by 
the disease. Materials and methods: This study had the participation of 26 volunteers, 13 from the Parkinson 
group (64.08 ± 6.87 years; 73.82 ± 13.03 kg; 1.66 ± 0.07 m) and 13 from the control group (62.73 ± 6.42 years; 
79.46 ± 11.40 kg; 1.71 ± 0.07 m). Peak Torque (PT) was measured in knee extensors using isokinetic dyna-
mometry, at a velocity of 90°.s-1. Student’s t-test was used to compare average values intra- and inter-groups 
(p < 0.05). Results: Absolute PT was significantly lower in the Parkinson group (119.29 ± 40.06 N.m) when 
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compared to the control group (145.15 ± 20.05 N.m). Among individuals with PD we found significantly lower 
values of muscle strength in the more affected, when compared to the less affected limb (119.29 ± 40.06 N.m 
vs. 128.86 ± 35.56 N.m; p < 0.05). Conclusion: Based on the results, we conclude that patients with PD showed 
a decreased isokinetic PT in knee extensors, and these findings are exacerbated in the limb more affected by 
the disease. 
 [P]
Keywords: Parkinson’s disease. Muscle strength. Torque. Isokinetic assessment. 
[B]
Resumo 
Introdução: Apesar do tremor, bradicinesia e rigidez serem os sintomas motores clássicos da doença de Parkinson (DP),
a fraqueza muscular também tem sido apontada como um dos mais importantes sintomas motores associados a 
essa doença, porém, essa condição ainda é pouco estudada e os resultados são inconsistentes. Objetivos: O presente 
estudo teve o propósito de comparar a força muscular do quadríceps entre indivíduos portadores de DP e indivíduos 
neurologicamente saudáveis pareados por idade e gênero. Foi comparada também a força muscular do membro 
mais acometido e menos acometido pela doença. Materiais e métodos: Participaram deste estudo 26 voluntários, 
13 do grupo Parkinson (GP: 64,08 ± 6,87 anos; 73,82 ± 13,03 Kg; 1,66 ± 0,07m;) e 13 do grupo controle (GC: 62,73 ± 
6,42 anos; 79,46 ± 11,40 kg; 1,71 ± 0,07 m). Foi mensurado o pico de torque (PT) dos extensores do joelho por meio 
da dinamometria isocinética, na velocidade de 90°.s-1. Foi utilizado o teste t para comparar as médias intra e entre 
os grupos (p < 0,05). Resultados: O PT absoluto foi significativamente menor no GP (119,29 ± 40,06 N.m) quando 
comparado ao GC (145,15 ± 20,05 N.m). Entre os indivíduos com DP, foram encontrados valores significativamente 
inferiores de força muscular do membro mais acometido quando comparado com o menos acometido (119,29 ± 
40,06 N.m vs. 128,86 ± 35,56 N.m; p < 0,05). Conclusão: Com base nos resultados, conclui-se que portadores da DP 
apresentam reduzido PT isocinético dos extensores do joelho, sendo esses achados exacerbados no membro mais 
acometido pela doença.
 [K]
Palavras chave: Doença de Parkinson. Força muscular. Torque. Avaliação isocinética. 
Introduction
Parkinson’s disease (PD) is an idiopathic and pro-
gressive disorder which affects 1% to 2% of the world 
population > 50 years, and its main feature is the severe 
loss of dopaminergic neurons in the substantia nigra, 
which is related to somatic motor activity (1, 2). The 
classic symptoms are bradykinesia, tremor, and rigidity 
(3). However, muscle weakness in PD has gained atten-
tion among researchers and it has been pointed out 
as one of the most important motor symptoms (2, 4).
Recent studies, using sensitive equipment to assess 
muscle strength, have identified decreased strength 
in patients with PD when compared to control in-
dividuals, who are neurologically healthy (2, 5, 6).
Furthermore, previous studies showed the rela-
tionship between muscle weakness and the decline 
in the basic and essential motor functions regarding 
the independence of these individuals, pointing out 
strength training as an important complementary 
approach (4, 7-10).
Berardelli et al. (11) indicates that muscle weak-
ness occur as a secondary cause of bradykinesia (11).
However, despite these indications, there are still 
many doubts with regard to the muscle strength beha-
vior of individuals affected by PD, when compared to 
neurologically healthy individuals of the same age 
and gender (10). There are few studies which quan-
tified muscle strength in PD and the results found 
are inconsistent (12). The specific cause of a possible 
strength deficit in these subjects is not known, yet, 
and it is still a matter of debate if it is of a central or 
peripheral origin, as well as if it is inherent to the 
disease or secondary to an external phenomenon.
In an attempt to shed some light on this issue, 
some authors also evaluated the difference in streng-
th between the limb more affected, when compared to 
the less affected, by the disease, however, the results 
are controversial. Nogaki et al. (13) evaluated the 
isokinetic strength of knee extension and flexion in 
patients with PD, at three different velocities, and it 
compared the strength of limbs. Peak Torque  (PT) 
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was significantly lower in the more affected limb only 
at the velocities of 90°.s-1 and 180°s-1, with no diffe-
rence at the velocity of 30°.s-1. On the other hand, 
Inkster et al. (14) evaluated the PT of knee extension 
in both limbs of individuals with PD, at the veloci-
ty of 45°.S-1, and found no difference between the 
more affected when compared to the less affected leg. 
Malicka et al. (15) evaluated the isokinetic strength in 
the quadriceps at higher velocities and it also identi-
fied no difference between the more affected and the 
less affected leg among subjects with PD.
Whereas the comparison of muscle strength 
between patients with PD and neurologically heal-
thy individuals, as well as the evaluation of muscle 
strength among patients with PD, has been poorly do-
cumented, and taking into account that the results are 
controversial, there is a need for conducting further 
studies in order to explain how much of the strength 
loss is a result of natural aging and how much is a 
result of PD. Thus, this study aimed to compare the 
isokinetic muscle strength of quadriceps between 
individuals with PD and neurologically healthy sub-
jects, matched for age and gender, as well as compare 
the muscle strength of the more affected to the less 
affected limb in individuals with PD.
Materials and methods
Subjects
This study was approved by the Research Ethics 
Committee of the Federal District  Health Council, 
under the Protocol 034/11, and the participants con-
firmed their participation in the investigation by sig-
ning a free and informed consent term; 26 subjects 
volunteered for the study, and 2 groups were formed.
The Parkinson group (PG) consisted of 13 male 
individuals recruited at the Parkinson’s Outpatient 
Ward of the the Federal District  Base Hospital, with 
diagnosed PD in accordance with the Criteria of the 
Brain Bank of London and rated between 1 and 3 
in the modified stage scale of the disease propo-
sed by Hoehn and Yahr (H & Y) (16). The control 
group (CG) consisted of 13 subjects matched for 
gender and age, with no neurological disease and 
apparently healthy.
The inclusion criteria were: 1) age between 50 
and 75 years; 2) individuals who were not invol-
ved in strength training in the last 6 months; 3) no 
significant health problems and/or disability which 
could be aggravated due to the experimental proto-
col; 4) individuals with PD who have shown no cog-
nitive deficits, according to the Mini-Mental Status 
Examination (MMSE) score, i.e. ≥ 24 points for literate 
or ≥ 17 for illiterate individuals (17, 18); 5) no other 
neurological disease in PG or any other condition 
limiting the ability to complete the study protocol.
Physical activity level
The physical activity level was determined 
by applying the International Physical Activity 
Questionnaire (IPAQ). The model used in this study 
corresponds to the official translation into Portuguese 
of the short version, previously validated for the 
Brazilian population (19). In order to categorize the 
results, we divided it into 2 groups: 1) insufficiently 
active; and 2) active (20).
Isokinetic torque peak
The quadriceps strength was measured using 
the isokinetic dynamometer Biodex System 3 
(Biodex Medical System, New York, USA), calibrated 
according to the manufacturer’s guidelines. After a 
detailed explanation of the evaluation, volunteers 
were carefully positioned on the device seat. The 
rotation axis of the dynamometer arm was aligned 
to the lateral femoral epicondyle. The force appli-
cation site was positioned around 2 inches away 
from the medial malleolus. The belts were fastened 
with velcro on the trunk, pelvis, and thigh in order 
to avoid possible compensatory movements. After 
heating on the equipment, the protocol consisted 
of 3 series of 10 concentric muscle contractions for 
bilateral knee extension, at the velocity of 90°.s-1. 
We asked the volunteers to perform the test with 
the greatest vigor possible and verbal encourage-
ment was used throughout the measurement. They 
reported which lower limb was more affected by 
the disease only in the day of assessment, which 
was carried out at the “on” phase, i.e. between 1 and 
2 hours after the use of medication. The amount 
recorded for subsequent analysis was the highest 
PT in the 3 series, which was expressed in absolute 
values  (N.m) and in values related to body mass 
(N.m/kg-1).
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For an analysis among the individuals in PG, we 
took into account data on the PT of the limb more 
affected and less affected by the disease. For an analy-
sis between groups, we used the PT values  of the 
limb more affected in PG and the right lower limb of 
CG. This choice was based on previous studies which 
found no isokinetic differences between the domi-
nant and non-dominant lower limbs in untrained 
individuals (14, 21).
Statistical analysis
We applied the Shapiro-Wilk normality test to all 
variables. For comparing the groups with regard to 
demographic characteristics, we employed Student’s 
t-test in cases where the variables had a Gaussian 
distribution. In cases where there was no normality 
in both groups, we used the non-parametric Mann 
Whitney test. For comparing the average values  be-
tween groups, we used Student’s t-test. For compa-
ring the average values  between the more affected 
and the less affected limb in PG, we used Student’s 
t-test for dependent samples. The significance level 
was p < 0.05. Data were analyzed by means of the 
software SPSS, version 17.0.
Results 
Considering the average values and the standard 
deviation of the sample characteristics, there was 
no statistically significant difference between these 
groups with regard to age, body mass, height, and 
body mass index (BMI). In the assessment of disease 
severity according to the modified H & Y scale, 3 sub-
jects were classified into 3 and most of them into 2. 
The results of the IPAQ in PG showed that 84.6% were 
regarded as active and 15.4% as insufficiently active. 
In CG, 61.5% were regarded as active and 38.5% as 
insufficiently active (Table 1).
The isokinetic PT of individuals from PG and CG 
are shown in Graphs 1 and 2. The absolute PT of qua-
driceps was significantly lower in individuals with PD 
when compared to CG. However, this difference did 
not reach statistical significance for PT with regard 
to body mass. 
When comparing muscle strength in the quadri-
ceps between individuals from PG, both the PT in 
absolute values and in values related to body mass 
were significantly lower in the limb more affected 
when compared to the limb less affected by the di-
sease (Graphs 3 and 4).
Discussion
The isokinetic dynamometer has been widely 
used to assess the muscle strength of elderly in-
dividuals both in clinical practice and in research 
protocols (22). Although the amount of references 
available is still restricted, there is a growing num-
ber of studies using this device to investigate the 
strength of different muscle groups in individuals 
with PD (2, 5). In this study, the results of PT asses-
sment in the isokinetic dynamometer showed a sig-
nificant difference in quadriceps strength in indivi-
duals with PD, when compared to subjects without 
the disease matched for age and gender, corrobo-
rating previous studies (5, 14). Durmus et al. (5) 
assessed the PT in quadriceps at 3 velocities (90°.s-1,
120°.s-1, and 150°.s-1) and it observed that muscle 
weakness in individuals with PD does not depend 
on velocity (5). Although evidence points out we-
akness as a characteristic of PD, the origin of this 
strength deficit has been put into question, whe-
ther peripheral or central, whether inherent to the 
disease or deriving from external factors.
Among the external factors, the level of usual 
physical activity practice seems to be important 
information in researches assessing muscle streng-
th in PD, since some studies show that individuals 
with PD have a lower level of physical activity and, 
thus they would be more exposed to the deleterious 
effects of immobility (23). However, studies taking 
into account the physical activity level in the asses-
sment of muscle strength in PD are still rare, it was 
reported by only one research (14). In this study, 
most participants from PG (84.6%) were regarded 
as physically active. This suggests that the lower 
ability to generate torque in PD may be mainly de-
rived from changes in the central nervous system 
and not from physical inactivity. Nevertheless, the 
physical activity level was assessed by means of a 
questionnaire, therefore, the theme requires fur-
ther investigation.
While some authors assessed strength during 
the “on” and “off” disease periods, this study was 
conducted only during the “on” disease period, in 
order to determine PT in the best motor status, 
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when it is expected that the patient spends most 
of her/his day with the treatment, including the 
practice of physical exercise (4, 5, 24, 25). Thus, 
the differences in PT found between the groups, 
even with a mild to moderate severity level (average 
of 2.3) and with the positive effect of anti-Parkin-
sonian drugs on motor performance, emphasizing 
that muscle weakness seems to be a clinical mani-
festation influenced by central changes caused by 
the disease.
The basal ganglia are a group of neuronal nuclei, 
located at the bottom of the brain, which are part of 
a complex network of circuits, including the motor 
























Graph 1 - Absolute peak torque (absolute PT) in the groups under assessment
Legend: * = significantly different when compared to Control Group (p < 0.05).
Source: Reseach data.
Table 1 – Characteristics of participants (average values ± standard deviation)
PG (n = 13) CG (n = 13) P - value
Age (years) 64,08 ± 6,87 62,73 ± 6,42 0,621
Body weight (kg)                73,82 ± 13,03               79,48 ± 11,40 0,130*
Height (m) 1,66 ± 0,07 1,71 ± 0,07 0,091
BMI (kg/m2) 26,76 ± 4,15 27,19 ± 2,56 0,754
Time of Diagnosis (years) 5,5 ± 3,01
H&Y 2,3 ± 0,48
PAL
Active 11 8
Insufficiently active 2 5
Legend: * = result of the Mann Whitney test; H & Y = Hoehn and Yahr (modified scale); PAL = physical activity level
Source: Research data.
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sequencing the individual’s motor acts. In PD, pro-
jections deriving from the motor areas of the cere-
bral cortex towards the striatum, one of the neuronal 
groupings of the basal ganglia, are changed due to the 
decreased release of dopamine from the substantia 























Graph 3 - Absolute peak torque (absolute PT) in the more affected and less affected limb in PG





























Graph 2 - Relative peak torque (relative PT) in the groups under assessment
Source: Research data.
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and striated pathway lead to a sequence of disarran-
gements in the other pathways of the basal ganglia, 
causing dysfunctions in motor responses (26). Thus, 
in PD, the disturbances occurring in the basal ganglia 
compromise the efferent pathway and they can cause 
a decreased activation of motor units and, as a con-
sequence, deficit in the production of muscle torque, 
as observed in this study.
It is also worth stressing that the disorders affec-
ting the basal ganglia generate disturbances in tha-
lamic connections to the prefrontal cortex and in the 
limbic integration for voluntary activities, with the 
possibility to cause an increase in perceived effort, 
lack of motivation, and difficulty for performing acti-
vities (27). These symptoms, characteristic of central 
fatigue, are often observed in individuals with PD 
(28) and, although not evaluated in this study, they 
can exert influence on the muscle strength deficits 
observed among this population.
By comparing the average values of PT between the 
two limbs in PG, the PT of the more affected limb was 
significantly lower. This result was found in previous 
studies (5, 6, 13). However, some authors found out that 
this difference in strength is dependent on velocity and 
that at velocities < 90°.s-1 there is no distinction in PT 
between limbs (6, 13). For instance, Inkster et al. (14) 
found no difference between limbs at the velocity of 
45°.s-1; Malicka et al. (15) assesed the PT of a bilateral 
knee extension at 60°.s-1 and 180°.s-1, and even at higher 
velocities, and it did not identify any difference between 
limbs more and less affected by the disease.
Although the results of this study show differences 
between limbs in terms of PT, it is believed that there 
is a manifestation of the bradykinesia sign in isoki-
netic tests at higher velocities, with the possibility 
of interfering with strength production, decreasing 
the PT generated (29). Moreover, it has been already 
proved in the literature that the higher the isokine-
tic velocity applied, the lower the ability to generate 
torque, both in adults and in elderly individuals (30).
Conclusion
Having the results observed as a basis, we conclu-
de that patients with PD have a significantly lower PT 
when compared to neurologically healthy individuals 
matched for age and gender. Moreover, it was observed 
that, at the velocity under assessment, muscle weakness 































Graph 4 - Relative peak torque (relative PT) in the more affected and less affected limb in PG
Legend: * = significantly different with regard to the less affected limb (p < 0.05).
Source: Research data.
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